Global Companion Diagnostic Technologies Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 11/23/2022
- NO OF PAGES
- 202
- CATEGORY
- Healthcare & Life Sciences
The competitive landscape analysis of Companion Diagnostic Technologies Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.
Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Companion Diagnostic Technologies Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Companion Diagnostic Technologies market is segmented by Company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2022-2030.
Global Companion Diagnostic Technologies Market: By Types
Immunohistochemistry
Molecular Diagnostics
Global Companion Diagnostic Technologies Market: By Applications
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Global Companion Diagnostic Technologies Market: Top Key Players
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Abbott Laboratories
Global Companion Diagnostic Technologies Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Companion Diagnostic Technologies Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Companion Diagnostic Technologies Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Companion Diagnostic Technologies market is segmented by Company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2022-2030.
Global Companion Diagnostic Technologies Market: By Types
Immunohistochemistry
Molecular Diagnostics
Global Companion Diagnostic Technologies Market: By Applications
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Global Companion Diagnostic Technologies Market: Top Key Players
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Abbott Laboratories
Global Companion Diagnostic Technologies Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Companion Diagnostic Technologies Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2030
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global Companion Diagnostic Technologies Market Share by Application: 2016 VS 2021 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Auto immune & Inflammation
1.3.6 Virology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Technologies Market Perspective (2016-2030)
2.2 Companion Diagnostic Technologies Growth Trends by Regions
2.2.1 Companion Diagnostic Technologies Market Size by Regions: 2016 VS 2021 VS 2030
2.2.2 Companion Diagnostic Technologies Historic Market Share by Regions (2016-2021)
2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Regions (2022-2030)
2.3 Companion Diagnostic Technologies Industry Dynamic
2.3.1 Companion Diagnostic Technologies Market Trends
2.3.2 Companion Diagnostic Technologies Market Drivers
2.3.3 Companion Diagnostic Technologies Market Challenges
2.3.4 Companion Diagnostic Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Technologies Players by Revenue
3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2016-2021)
3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2016-2021)
3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue
3.4 Global Companion Diagnostic Technologies Market Concentration Ratio
3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2020
3.5 Companion Diagnostic Technologies Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Technologies Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Technologies Breakdown Data by Type
4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2016-2021)
4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2022-2030)
5 Companion Diagnostic Technologies Breakdown Data by Application
5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2016-2021)
5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2022-2030)
6 North America
6.1 North America Companion Diagnostic Technologies Market Size (2016-2030)
6.2 North America Companion Diagnostic Technologies Market Size by Type
6.2.1 North America Companion Diagnostic Technologies Market Size by Type (2016-2021)
6.2.2 North America Companion Diagnostic Technologies Market Size by Type (2022-2030)
6.2.3 North America Companion Diagnostic Technologies Market Size by Type (2016-2030)
6.3 North America Companion Diagnostic Technologies Market Size by Application
6.3.1 North America Companion Diagnostic Technologies Market Size by Application (2016-2021)
6.3.2 North America Companion Diagnostic Technologies Market Size by Application (2022-2030)
6.3.3 North America Companion Diagnostic Technologies Market Size by Application (2016-2030)
6.4 North America Companion Diagnostic Technologies Market Size by Country
6.4.1 North America Companion Diagnostic Technologies Market Size by Country (2016-2021)
6.4.2 North America Companion Diagnostic Technologies Market Size by Country (2022-2030)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Companion Diagnostic Technologies Market Size (2016-2030)
7.2 Europe Companion Diagnostic Technologies Market Size by Type
7.2.1 Europe Companion Diagnostic Technologies Market Size by Type (2016-2021)
7.2.2 Europe Companion Diagnostic Technologies Market Size by Type (2022-2030)
7.2.3 Europe Companion Diagnostic Technologies Market Size by Type (2016-2030)
7.3 Europe Companion Diagnostic Technologies Market Size by Application
7.3.1 Europe Companion Diagnostic Technologies Market Size by Application (2016-2021)
7.3.2 Europe Companion Diagnostic Technologies Market Size by Application (2022-2030)
7.3.3 Europe Companion Diagnostic Technologies Market Size by Application (2016-2030)
7.4 Europe Companion Diagnostic Technologies Market Size by Country
7.4.1 Europe Companion Diagnostic Technologies Market Size by Country (2016-2021)
7.4.2 Europe Companion Diagnostic Technologies Market Size by Country (2022-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Technologies Market Size (2016-2030)
8.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2022-2030)
8.2.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2030)
8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2022-2030)
8.3.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2030)
8.4 Asia-Pacific Companion Diagnostic Technologies Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2022-2030)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Technologies Market Size (2016-2030)
9.2 Latin America Companion Diagnostic Technologies Market Size by Type
9.2.1 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2021)
9.2.2 Latin America Companion Diagnostic Technologies Market Size by Type (2022-2030)
9.2.3 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2030)
9.3 Latin America Companion Diagnostic Technologies Market Size by Application
9.3.1 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2021)
9.3.2 Latin America Companion Diagnostic Technologies Market Size by Application (2022-2030)
9.3.3 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2030)
9.4 Latin America Companion Diagnostic Technologies Market Size by Country
9.4.1 Latin America Companion Diagnostic Technologies Market Size by Country (2016-2021)
9.4.2 Latin America Companion Diagnostic Technologies Market Size by Country (2022-2030)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Technologies Market Size (2016-2030)
10.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2022-2030)
10.2.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2030)
10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2022-2030)
10.3.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2030)
10.4 Middle East & Africa Companion Diagnostic Technologies Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2022-2030)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Dako (Agilent Technologies)
11.1.1 Dako (Agilent Technologies) Company Details
11.1.2 Dako (Agilent Technologies) Business Overview
11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction
11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.1.5 Dako (Agilent Technologies) Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Details
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Companion Diagnostic Technologies Introduction
11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.2.5 Qiagen Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Companion Diagnostic Technologies Introduction
11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction
11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction
11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Details
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Companion Diagnostic Technologies Introduction
11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.6.5 bioMerieux Recent Development
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Details
11.7.2 Myriad Genetics Business Overview
11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction
11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.7.5 Myriad Genetics Recent Development
11.8 Resonance Health Ltd.
11.8.1 Resonance Health Ltd. Company Details
11.8.2 Resonance Health Ltd. Business Overview
11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction
11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.8.5 Resonance Health Ltd. Recent Development
11.9 Leica Microsystems
11.9.1 Leica Microsystems Company Details
11.9.2 Leica Microsystems Business Overview
11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction
11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.9.5 Leica Microsystems Recent Development
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Technologies Introduction
11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.10.5 Danaher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2030
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global Companion Diagnostic Technologies Market Share by Application: 2016 VS 2021 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Auto immune & Inflammation
1.3.6 Virology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Technologies Market Perspective (2016-2030)
2.2 Companion Diagnostic Technologies Growth Trends by Regions
2.2.1 Companion Diagnostic Technologies Market Size by Regions: 2016 VS 2021 VS 2030
2.2.2 Companion Diagnostic Technologies Historic Market Share by Regions (2016-2021)
2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Regions (2022-2030)
2.3 Companion Diagnostic Technologies Industry Dynamic
2.3.1 Companion Diagnostic Technologies Market Trends
2.3.2 Companion Diagnostic Technologies Market Drivers
2.3.3 Companion Diagnostic Technologies Market Challenges
2.3.4 Companion Diagnostic Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Technologies Players by Revenue
3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2016-2021)
3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2016-2021)
3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue
3.4 Global Companion Diagnostic Technologies Market Concentration Ratio
3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2020
3.5 Companion Diagnostic Technologies Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Technologies Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Technologies Breakdown Data by Type
4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2016-2021)
4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2022-2030)
5 Companion Diagnostic Technologies Breakdown Data by Application
5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2016-2021)
5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2022-2030)
6 North America
6.1 North America Companion Diagnostic Technologies Market Size (2016-2030)
6.2 North America Companion Diagnostic Technologies Market Size by Type
6.2.1 North America Companion Diagnostic Technologies Market Size by Type (2016-2021)
6.2.2 North America Companion Diagnostic Technologies Market Size by Type (2022-2030)
6.2.3 North America Companion Diagnostic Technologies Market Size by Type (2016-2030)
6.3 North America Companion Diagnostic Technologies Market Size by Application
6.3.1 North America Companion Diagnostic Technologies Market Size by Application (2016-2021)
6.3.2 North America Companion Diagnostic Technologies Market Size by Application (2022-2030)
6.3.3 North America Companion Diagnostic Technologies Market Size by Application (2016-2030)
6.4 North America Companion Diagnostic Technologies Market Size by Country
6.4.1 North America Companion Diagnostic Technologies Market Size by Country (2016-2021)
6.4.2 North America Companion Diagnostic Technologies Market Size by Country (2022-2030)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Companion Diagnostic Technologies Market Size (2016-2030)
7.2 Europe Companion Diagnostic Technologies Market Size by Type
7.2.1 Europe Companion Diagnostic Technologies Market Size by Type (2016-2021)
7.2.2 Europe Companion Diagnostic Technologies Market Size by Type (2022-2030)
7.2.3 Europe Companion Diagnostic Technologies Market Size by Type (2016-2030)
7.3 Europe Companion Diagnostic Technologies Market Size by Application
7.3.1 Europe Companion Diagnostic Technologies Market Size by Application (2016-2021)
7.3.2 Europe Companion Diagnostic Technologies Market Size by Application (2022-2030)
7.3.3 Europe Companion Diagnostic Technologies Market Size by Application (2016-2030)
7.4 Europe Companion Diagnostic Technologies Market Size by Country
7.4.1 Europe Companion Diagnostic Technologies Market Size by Country (2016-2021)
7.4.2 Europe Companion Diagnostic Technologies Market Size by Country (2022-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Technologies Market Size (2016-2030)
8.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2022-2030)
8.2.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2030)
8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2022-2030)
8.3.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2030)
8.4 Asia-Pacific Companion Diagnostic Technologies Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2022-2030)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Technologies Market Size (2016-2030)
9.2 Latin America Companion Diagnostic Technologies Market Size by Type
9.2.1 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2021)
9.2.2 Latin America Companion Diagnostic Technologies Market Size by Type (2022-2030)
9.2.3 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2030)
9.3 Latin America Companion Diagnostic Technologies Market Size by Application
9.3.1 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2021)
9.3.2 Latin America Companion Diagnostic Technologies Market Size by Application (2022-2030)
9.3.3 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2030)
9.4 Latin America Companion Diagnostic Technologies Market Size by Country
9.4.1 Latin America Companion Diagnostic Technologies Market Size by Country (2016-2021)
9.4.2 Latin America Companion Diagnostic Technologies Market Size by Country (2022-2030)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Technologies Market Size (2016-2030)
10.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2022-2030)
10.2.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2030)
10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2022-2030)
10.3.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2030)
10.4 Middle East & Africa Companion Diagnostic Technologies Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2022-2030)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Dako (Agilent Technologies)
11.1.1 Dako (Agilent Technologies) Company Details
11.1.2 Dako (Agilent Technologies) Business Overview
11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction
11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.1.5 Dako (Agilent Technologies) Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Details
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Companion Diagnostic Technologies Introduction
11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.2.5 Qiagen Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Companion Diagnostic Technologies Introduction
11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction
11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction
11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Details
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Companion Diagnostic Technologies Introduction
11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.6.5 bioMerieux Recent Development
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Details
11.7.2 Myriad Genetics Business Overview
11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction
11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.7.5 Myriad Genetics Recent Development
11.8 Resonance Health Ltd.
11.8.1 Resonance Health Ltd. Company Details
11.8.2 Resonance Health Ltd. Business Overview
11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction
11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.8.5 Resonance Health Ltd. Recent Development
11.9 Leica Microsystems
11.9.1 Leica Microsystems Company Details
11.9.2 Leica Microsystems Business Overview
11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction
11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.9.5 Leica Microsystems Recent Development
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Technologies Introduction
11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.10.5 Danaher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI